Endocrine System Diseases  >>  Ovidrel (choriogonadotropin alfa)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ovidrel (choriogonadotropin alfa) / EMD Serono
ATTAC-PCO, NCT01185704 / 2007-007932-25: Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)

Completed
3
136
Europe
Cetrorelix acetate, Cetrotide®, Recombinant Human Choriogonadotropin (r-hCG), Ovitrelle®, Recombinant human follicle stimulating hormone (r-hFSH)
Merck KGaA, Darmstadt, Germany, Merck Serono S.A.S, France
Polycystic Ovarian Syndrome
10/11
02/12

Download Options